In 2013, systemic therapy was introduced into the treatment of locally advanced (laBCC) and metastatic basal cell carcinoma (mBCC). Meanwhile, immunotherapy has been approved in this indication as well. Additional immunotherapies and other classes of drugs including combination regimens are currently being investigated in clinical trials. These agents might considerably expand the therapeutic armamentarium for laBCC and mBCC in the future.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ddg.15020 | DOI Listing |
Publication Analysis
Top Keywords
basal cell
8
cell carcinoma
8
therapeutic developments
4
developments basal
4
carcinoma 2013
4
2013 systemic
4
systemic therapy
4
therapy introduced
4
introduced treatment
4
treatment locally
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!